AdaptHealth (AHCO) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.84% |
| Dec 31, 2025 | 13.73% |
| Sep 30, 2025 | -0.57% |
| Jun 30, 2025 | 69.58% |
| Mar 31, 2025 | -36.49% |
| Dec 31, 2024 | 4.16% |
| Sep 30, 2024 | -27.06% |
| Jun 30, 2024 | 303.76% |
| Mar 31, 2024 | -68.42% |
| Dec 31, 2023 | 57.10% |
| Sep 30, 2023 | 14.50% |
| Jun 30, 2023 | -38.45% |
| Mar 31, 2023 | 44.70% |
| Dec 31, 2022 | -9.44% |
| Sep 30, 2022 | 3.43% |
| Jun 30, 2022 | 55.71% |
| Mar 31, 2022 | -34.16% |
| Dec 31, 2021 | 272.07% |
| Sep 30, 2021 | -79.01% |
| Jun 30, 2021 | 603.18% |
| Mar 31, 2021 | -63.49% |
| Dec 31, 2020 | 46.87% |
| Sep 30, 2020 | -60.43% |
| Jun 30, 2020 | 255.32% |
| Mar 31, 2020 | 41.38% |
| Dec 31, 2019 | 0.62% |
| Sep 30, 2019 | 74.81% |
| Jun 30, 2019 | -39.60% |
| Mar 31, 2019 | -76.71% |
| Dec 31, 2018 | 19,653.78% |
| Sep 30, 2018 | 33.16% |
| Jun 30, 2018 | -40.27% |